Latest news
Tap Water Contaminants Linked to Uterine Cancer Risk - Cancer HealthCancer Health · Thu, 06 Aug 2026 05:47:34 GMTHair Relaxer Lawsuit - Motley RiceMotley Rice · Tue, 04 Aug 2026 07:00:00 GMTKaryopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sat, 01 Aug 2026 06:33:05 GMTSelinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 20:06:29 GMTSelinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - OncLiveOncLive · Fri, 31 Jul 2026 17:22:55 GMTSelinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 14:37:53 GMTXpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis - Fierce PharmaFierce Pharma · Fri, 31 Jul 2026 14:00:00 GMTSelinexor Misses Primary Endpoint in Endometrial Cancer Trial - MPR - Medical Professionals ReferenceMedical Professionals Reference · Fri, 31 Jul 2026 04:00:00 GMT